Long-term impact of the U.S. Armed forces Zero-Tolerance drug policy on female veterans

Background: In 1980, the U.S. military instituted a zero-tolerance policy for illicit substance use that led to a reduction in such use during military services. Long-term post-military effects have not been studied.

Methods: National survey data from 2012-2013 were used to compared veteran versus non-veteran differences in sociodemographic, behavioral and substance use and psychiatric diagnoses among women by cohort (i.e., those younger than 52 who would have entered the military under the no tolerance policy, and those older than 52 who would have entered before this policy was implemented). Multivariate interaction analyses between cohorts and veteran status were used to identify significant changes in veteran-non-veteran differences between these age cohorts on during the decades following the implementation of the zero-tolerance policy.

Results: Significant interactions primarily involved substance use diagnoses which were less frequent among veterans than non-veterans in the younger group of women, in contrast to the older group in which veterans had greater rates of substance use than non-veterans. These patterns were less robust for alcohol than substance use disorders and were not significant for psychiatric disorders.

Conclusion: The zero-tolerance policy appears to have had a long-term effect resulting in less substance use disorder and, to some extent, less alcohol use disorder among veterans as compared to non-veterans who served in the military after the zero-tolerance policy was implemented.

Keywords: DSM-5; Female veterans; NESARC-III; substance use.

Similar articles

Rosenheck R, Stefanovics E, Rhee TG. Rosenheck R, et al. Psychiatr Q. 2021 Sep;92(3):1129-1145. doi: 10.1007/s11126-021-09882-2. Epub 2021 Feb 15. Psychiatr Q. 2021. PMID: 33587258

Evans EA, Upchurch DM, Simpson T, Hamilton AB, Hoggatt KJ. Evans EA, et al. Soc Psychiatry Psychiatr Epidemiol. 2018 Apr;53(4):421-435. doi: 10.1007/s00127-017-1463-0. Epub 2017 Nov 29. Soc Psychiatry Psychiatr Epidemiol. 2018. PMID: 29188311

Agaku I, Odani S, Nelson JR. Agaku I, et al. Am J Prev Med. 2020 Nov;59(5):733-741. doi: 10.1016/j.amepre.2020.04.027. Epub 2020 Oct 2. Am J Prev Med. 2020. PMID: 33012620

Kelsall HL, Wijesinghe MS, Creamer MC, McKenzie DP, Forbes AB, Page MJ, Sim MR. Kelsall HL, et al. Epidemiol Rev. 2015;37:38-54. doi: 10.1093/epirev/mxu014. Epub 2015 Jan 14. Epidemiol Rev. 2015. PMID: 25589053 Review.

Dworkin ER, Bergman HE, Walton TO, Walker DD, Kaysen DL. Dworkin ER, et al. Alcohol Res. 2018;39(2):161-169. Alcohol Res. 2018. PMID: 31198655 Free PMC article. Review.

Cited by

Singh K, Timko C, Yu M, Taylor E, Blue-Howells J, Finlay AK. Singh K, et al. Health Justice. 2024 Apr 19;12(1):18. doi: 10.1186/s40352-024-00274-9. Health Justice. 2024. PMID: 38639813 Free PMC article.

MeSH terms

Alcoholism*